Andrew McCarty, MS, CGC

As a board-certified genetic counselor, I have extensive experience providing care and guidance for individuals and families affected by Hereditary Hemorrhagic Telangiectasia (HHT). From 2015 to 2019 and 2022 to 2024, I worked with the Hematology and Genetics departments at Children's Hospital, where I supported patients in understanding the genetic aspects of HHT, including risk assessment, testing, and management. My telehealth practice now allows me to reach patients across multiple states, providing accessible and personalized genetic counseling to help them navigate their diagnosis and treatment options with confidence.